N-Oxalylglycine
CAS No. 5262-39-5
N-Oxalylglycine ( Oxalylglycine )
Catalog No. M27438 CAS No. 5262-39-5
N-Oxalylglycine is a cell permeable inhibitor of α-ketoglutarate-dependent enzymes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 38 | In Stock |
|
100MG | 56 | In Stock |
|
200MG | 75 | In Stock |
|
500MG | 131 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Oxalylglycine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Oxalylglycine is a cell permeable inhibitor of α-ketoglutarate-dependent enzymes.
-
DescriptionN-Oxalylglycine is a cell permeable inhibitor of α-ketoglutarate-dependent enzymes.
-
SynonymsOxalylglycine
-
PathwayOthers
-
TargetOther Targets
-
RecptorIL Receptor;NF-κB;Immunology & Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5262-39-5
-
Formula Weight147.1
-
Molecular FormulaC4H5NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CNC(=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li P, et al. Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico. J Ethnopharmacol. 2016 Dec 24;194:658-667.
molnova catalog
related products
-
Alashinol G
Alashinol G is isolated from the stem bark of Syringa pinnatifolia, a Mongolian folk medicine with anti-myocardial ischaemic effects.
-
L(+)-Ornithine hydro...
L-ornithine hydrochloride has an antifatigue effect by increasing the efficiency of energy consumption and promoting the excretion of ammonia. It is one of the key reactants in the urea cycle.
-
[Ala1,?3,?11,?15]?-?...
[Ala1,3,11,15]-Endothelin (TFA) is a highly selective for endothelin A (ETA) and endothelin B (ETB) receptor.[Ala1,?3,?11,?15]?-?Endothelin is a selective ETB endothelin receptor agonist (IC50 values are 0.33 and 2200 nM for displacing [125I]-ET-1 from ETB and ETA receptors respectively).